Audien Hearing Atom vs Lexie B3

The Audien Hearing Atom is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.3/5 in our lab testing. At $89, it represents one of the most affordable entry points into amplification, though its performance reflects that positioning with a rank of #52 among 65 OTC hearing aids tested. The Atom's standout strength is its excellent feedback handling, scoring a perfect 5.0/5—above the category average by 0.46 points. This means users can expect stable amplification without the whistling that can plague some budget devices. However, speech performance is more limited: speech in quiet scores a mixed 2.6/5 (0.15 points below category average), while speech in noise drops to a low 1.0/5 (0.48 points below average). A significant limitation is the complete lack of music streaming capability, scoring 0.0/5—nearly 2 points below the already-modest category average. Own-voice comfort also falls below average at 2.1/5. These results suggest the Atom is designed purely for basic amplification rather than multimedia use. The Atom may suit buyers seeking the most affordable path to mild amplification who prioritize stability over advanced features. However, several competitors in the same price range offer substantially better performance—some scoring a full point higher. Those willing to consider alternatives may find meaningfully better speech clarity and additional capabilities without significant price increases.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.